Abstract
VA-ECMO is the mainstay of treatment for refractory cardiogenic shock. However, it has been associated with increased LV loading. The Intra-Aortic Balloon Pump (IABP) has been utilised to assist in weaning of VA-ECMO patients, as some studies have shown an improvement in survival. Yet the evidence on its improvement in LV venting, afterload reduction, coronary and cerebral flow are conflicting, and the procedural risks may outweigh any potential benefit. Our aim was to determine the impact of the addition of an IABP to ECMO in various simulations of cardiac failure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
